We are delighted to announce that Alexion, AstraZeneca Rare Disease, ANZ has joined CTIQ’s Steering Committee as our newest member. Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and delivery of life-changing medicines. A pioneering leader in rare disease for more than three decades, […]
Uncategorised
Safer Care Victoria joins CT:IQ
We’re thrilled to announce the newest member to CT:IQ, Safer Care Victoria. Dedicated to enhancing healthcare quality and safety, Safer Care Victoria works tirelessly to prevent patient harm, identify and deliver service improvements, and engage with consumers. With their vision of outstanding healthcare for all Victorians, and a commitment to collaboration and innovation, they bring […]
CT:IQ welcomes newest Steering Committee Member, Fortrea
CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee. Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing […]